Blood coagulation components in GtoPdb v.2022.1

Authors

DOI:

https://doi.org/10.2218/gtopdb/F853/2022.1

Abstract

Coagulation as a process is interpreted as a mechanism for reducing excessive blood loss through the generation of a gel-like clot local to the site of injury. The process involves the activation, adhesion (see Integrins), degranulation and aggregation of platelets, as well as proteins circulating in the plasma. The coagulation cascade involves multiple proteins being converted to more active forms from less active precursors (for example, prothrombin [Factor II] is converted to thrombin [Factor IIa]), typically through proteolysis (see Proteases). Listed here are the components of the coagulation cascade targeted by agents in current clinical usage or at an advanced level of development.

Published

31-Mar-2022

Issue

Section

Summaries

How to Cite

“Blood coagulation components in GtoPdb v.2022.1” (2022) IUPHAR/BPS Guide to Pharmacology CITE, 2022(1). doi:10.2218/gtopdb/F853/2022.1.